Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
301,924,050
-
Share change
-
+5,338,077
-
Total reported value
-
$11,117,499,712
-
Put/Call ratio
-
95%
-
Price per share
-
$36.80
-
Number of holders
-
808
-
Value change
-
+$193,375,712
-
Number of buys
-
297
-
Number of sells
-
450
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q4 2020
As of 31 Dec 2020,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
808 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
301,924,050 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, ROYAL BANK OF CANADA, RENAISSANCE TECHNOLOGIES LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Black Creek Investment Management Inc..
This page lists
808
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.